Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07488195 · ClinicalTrials.gov registry record · NA
A Study Of Phototherapy In Patients With Dementia To Improve BPSD
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07488195: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07488195 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07488195, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.
Interventions
- OTHER Phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07488195
The ClinicalTrials.gov registry entry for NCT07488195 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phototherapy is the first listed.
NCT07488195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07488195 about?
NCT07488195 is a clinical study titled "A Study Of Phototherapy In Patients With Dementia To Improve BPSD". The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.
What is the current status of trial NCT07488195?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07488195?
The interventions under investigation include: Phototherapy (OTHER).
Who is sponsoring clinical trial NCT07488195?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.